HZNP
HORIZON THERAPEUTICS PLC
HORIZON THERAPEUTICS PLC historical holders
total: 5
Alta Fox Capital Management HORIZON THERAPEUTICS PLC transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2023 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2023 Q2
Connor Haley has been an institutional investor in HORIZON THERAPEUTICS PLC (HZNP) since 2023 Q1. According to 2026 Q1 report, Connor Haley doesn't hold any shares. The fund/company first acquired HZNP in 2023 Q1, initially purchasing 44,500 shares. Since the initial investment, Alta Fox Capital Management has made 1 more transaction in this position.
When did Connor Haley exit their HZNP position?
Connor Haley no longer holds HORIZON THERAPEUTICS PLC (HZNP). They sold off their entire position in 2023 Q2, closing out an investment that began in 2023 Q1.
When did Connor Haley first invest in HZNP?
Connor Haley first invested in HORIZON THERAPEUTICS PLC (HZNP) in 2023 Q1 at the reported quarter-end price of $109.14 per share, acquiring 44,500 shares in their initial purchase.
What is Connor Haley's average cost basis for HZNP?
Based on historical transaction data, Connor Haley's estimated cost basis for HORIZON THERAPEUTICS PLC (HZNP) is approximately $109.14 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $109.14
- Weighted AVG sell price:
- $109.14
HZNP transactions history by Alta Fox Capital Management
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q2
|
0.00%
|
0
|
$109.14
|
|
-100% (-44,500)
|
-4.59%
|
|
2023 Q1
|
4.59%
|
44,500
|
$109.14
|
$4,856,730
|
new
|
+4.59%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.